Dr Kajal Katariya

Dr Kajal Katariya

Resident doctor

M.P.Shah medical College Jamnagar

Profile ID RP-002-6905 Joined 2024-05-07 1 article
0Connections
7
Total Views
1
Total Publications
17
Publication Views

Articles(1)

Authors: Kajalben Jashubhai Katariya*, Tushar Gosai, Akshay Hasmukhbhai Parmar

DOI: 10.18231/j.ijpp.2024.008

Volume11
Issue1
Pages44-49
Abstract

Background: Hypertension (HTN) is a chronic condition with severe complications, so early detection and effective management are essential to prevent cardiovascular events and reduce the associated economic burden. This study aims to compare the cost-effectiveness of enalapril, amlodipine, and their combination in terms of blood pressure reduction, considering overall efficacy and economic implications. Materials and Methods: A prospective, observational cost-effectiveness analysis was conducted in 150 newly diagnosed hypertensive patients who were prescribed either enalapril (5 mg), amlodipine (5 mg), or enalapril plus amlodipine (2.5 mg each). The primary outcome was the difference in systolic and diastolic blood pressure between baseline and follow-up, as well as the evaluation of overall efficacy and cost. Based on the data, statistical analysis was carried out using ANOVA and post hoc Tukey tests for drug efficacy, and cost-effectiveness was compared using MS Excel. Results: After 30 days, all treatments significantly reduced systolic and diastolic blood pressure (p = 0.0001). The combination therapy with a lower dose showed superior efficacy in blood pressure reduction and was most cost-effective, requiring less expense for a 1 mmHg reduction in blood pressure compared to individual drugs with a higher dose. Quality of life assessment favored low-dose combination therapy, with fewer reported adverse effects. The combinationof amlodipine and enalapril at a lower dose demonstrated superior cost-effectiveness, efficacy in blood pressure reduction, and a favorable impact on patients' quality of life compared to individual drugs at a higher dose. This suggests that combination therapy may be a preferred option in the management of hypertension, emphasizing the importance of considering both clinical and economic factors in treatment decisions. Keywords: Cost-effective analysis, Enalapril, Amlodipine, Hypertension, Quality of life

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

VK
VARUN KUMAR
0 publications
BG
Bhupendra Gupta
0 publications
MB
Monika Bharti
0 publications
SB
Sudip Bhattacharjee
0 publications
NN
Nilam Navinbhai Pala
0 publications
SK
Surendra Kumar Pal
0 publications
DB
Daksh Bhatnagar
0 publications
J
jgjgg
adada
0 publications
MD
Mustafa D Younus
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

1 Publications

0 Contributions

Nothing added yet.

Filter